Zansecimab, CAS 2415205-37-5

Product Description: Zansecimab (LY-3127804) is an immunoglobulin G4-kappa, a monoclonal antibody against angiopoietin 2 (Ang 2). Zansecimab has potential applications in angiogenesis and immune regulation[1][2][3].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Yen CC, et al. Safety of ramucirumab treatment in patients with advanced hepatocellular carcinoma and elevated alpha-fetoprotein. Expert Opin Drug Saf. 2022 Feb;21(2):157-166./[2]Wang Y, et al. Angiogenesis as a potential treatment strategy for rheumatoid arthritis. Eur J Pharmacol. 2021 Nov 5;910:174500.

CAS Number: 2415205-37-5

Molecular Weight: N/A

Compound Purity: 95.00

Research Area: Inflammation/Immunology; Cancer

Solubility: 10 mM in DMSO

Target: Tie

• Artikelnummer: MEXHY-P99510-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99510-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated